Zacks: Analysts Anticipate Israel Chemicals Ltd (ICL) Will Announce Earnings of $0.10 Per Share

Wall Street brokerages forecast that Israel Chemicals Ltd (NYSE:ICL) will post earnings of $0.10 per share for the current fiscal quarter, Zacks Investment Research reports. Zero analysts have provided estimates for Israel Chemicals’ earnings, with estimates ranging from $0.09 to $0.10. Israel Chemicals posted earnings per share of $0.08 in the same quarter last year, which would suggest a positive year over year growth rate of 25%. The firm is scheduled to issue its next earnings results on Thursday, May 9th.

According to Zacks, analysts expect that Israel Chemicals will report full-year earnings of $0.41 per share for the current fiscal year, with EPS estimates ranging from $0.40 to $0.42. For the next year, analysts anticipate that the business will post earnings of $0.44 per share, with EPS estimates ranging from $0.43 to $0.45. Zacks Investment Research’s EPS averages are a mean average based on a survey of sell-side analysts that that provide coverage for Israel Chemicals.

Israel Chemicals (NYSE:ICL) last posted its earnings results on Wednesday, February 6th. The basic materials company reported $0.10 EPS for the quarter, topping the consensus estimate of $0.09 by $0.01. Israel Chemicals had a return on equity of 12.33% and a net margin of 22.32%. The firm had revenue of $1.41 billion for the quarter, compared to analyst estimates of $1.37 billion. During the same period last year, the company earned $0.12 earnings per share. Israel Chemicals’s revenue for the quarter was up 3.6% compared to the same quarter last year.

A number of equities research analysts have commented on ICL shares. Zacks Investment Research upgraded Israel Chemicals from a “hold” rating to a “buy” rating and set a $6.00 target price on the stock in a research report on Wednesday, December 19th. ValuEngine downgraded Israel Chemicals from a “buy” rating to a “hold” rating in a report on Monday. Finally, Stephens assumed coverage on Israel Chemicals in a report on Tuesday, March 12th. They issued an “overweight” rating on the stock. Three research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. The company has a consensus rating of “Hold” and an average price target of $6.11.

Shares of NYSE:ICL traded down $0.09 during trading on Thursday, reaching $5.25. The stock had a trading volume of 1,655 shares, compared to its average volume of 259,820. Israel Chemicals has a 1-year low of $4.14 and a 1-year high of $6.90. The company has a debt-to-equity ratio of 0.46, a current ratio of 1.39 and a quick ratio of 0.75. The firm has a market capitalization of $6.83 billion, a PE ratio of 14.26, a P/E/G ratio of 1.35 and a beta of 0.86.

Several hedge funds have recently bought and sold shares of ICL. Arete Wealth Advisors LLC acquired a new position in Israel Chemicals during the 4th quarter worth $82,000. Quadrant Capital Group LLC boosted its position in shares of Israel Chemicals by 6,322.8% during the 4th quarter. Quadrant Capital Group LLC now owns 15,479 shares of the basic materials company’s stock worth $87,000 after acquiring an additional 15,238 shares in the last quarter. BlackRock Inc. boosted its position in shares of Israel Chemicals by 5.6% during the 4th quarter. BlackRock Inc. now owns 287,546 shares of the basic materials company’s stock worth $1,628,000 after acquiring an additional 15,307 shares in the last quarter. Credit Suisse AG boosted its position in shares of Israel Chemicals by 2.0% during the 3rd quarter. Credit Suisse AG now owns 922,166 shares of the basic materials company’s stock worth $5,561,000 after acquiring an additional 18,251 shares in the last quarter. Finally, Bank of New York Mellon Corp boosted its position in shares of Israel Chemicals by 1.0% during the 3rd quarter. Bank of New York Mellon Corp now owns 1,982,567 shares of the basic materials company’s stock worth $11,955,000 after acquiring an additional 19,052 shares in the last quarter. Hedge funds and other institutional investors own 10.04% of the company’s stock.

About Israel Chemicals

Israel Chemicals Ltd. operates as a specialty minerals company worldwide. The company operates through two segments, Essential Minerals and Specialty Solutions. The company extracts potash from the Dead Sea; mines and produces potash, salt, and Polysulphate; and produces, markets, and sells pure magnesium and magnesium alloys, as well as produces dry carnallite and related by-products, including chlorine and sylvinite.

Further Reading: What are the Different Types of Leveraged Buyouts?

Get a free copy of the Zacks research report on Israel Chemicals (ICL)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Israel Chemicals (NYSE:ICL)

Receive News & Ratings for Israel Chemicals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Israel Chemicals and related companies with MarketBeat.com's FREE daily email newsletter.